Welch & Forbes’s T2 Biosystems, Inc TTOO Stock Holding History

Welch & Forbes’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27	Closed	-$124K	–	400
2021 Q3	$124K	Buy	+27	New	+$136K	﹤0.01%	384

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Welch & Forbes's TTOO Position: Q4 2021 in Review

Welch & Forbes sold out of T2 Biosystems, Inc (TTOO) in Q4 2021, closing a stake of 27 shares — an estimated $124K sold.

Welch & Forbes first reported a position in TTOO in Q3 2021 and held it in 1 quarter. The position peaked at $124K in Q3 2021. 70 funds tracked by Wall St. Rank hold TTOO as of Q4 2021.

Welch & Forbes reported no remaining T2 Biosystems, Inc position as of Q4 2021 after selling out during the quarter.
Welch & Forbes sold 27 T2 Biosystems, Inc shares in Q4 2021, an estimated $124K.
Welch & Forbes first reported a position in T2 Biosystems, Inc in Q3 2021 and held it in 1 quarter.
Welch & Forbes's T2 Biosystems, Inc position peaked at $124K in Q3 2021.
70 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2021.

Based on Welch & Forbes's 13F filing for Q4 2021, filed 19 Jan 2022.